Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
04/2011
04/05/2011US7919080 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity
04/05/2011CA2491893C Composition and bag for preservation of blood platelets
04/05/2011CA2466487C Augmentation of organ function
04/05/2011CA2346119C A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5
04/05/2011CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
04/02/2011CA2715959A1 Surgical compositions
03/2011
03/31/2011WO2011037416A2 Method of manufacturing cell spheroids which are mixed cellular complexes for cell transplantation and usage thereof
03/31/2011WO2011037367A2 Highly-efficient manufacturing method of induced pluripotent stem cells and induced pluripotent stem cells produced by the method
03/31/2011WO2011036632A1 Composition comprising a haematic component and its use for the treatment of degenerative joint disease
03/31/2011WO2011036564A2 Hyperblebbing shigella strains
03/31/2011WO2011036539A1 Therapy for enteric infections
03/31/2011WO2011036304A1 Leaven-based mixture
03/31/2011WO2010135610A3 Cell therapy for brain tissue damage
03/31/2011WO2010121122A3 Biomechanical induction of hematopoiesis
03/31/2011WO2010121008A3 Methods for enhancing hematopoietic progenitor cell engraftment
03/31/2011WO2010117974A3 Hiv-resistant stem cells and uses thereof
03/31/2011WO2010115050A3 Embryonic stem cell specific micrornas promote induced pluripotency
03/31/2011WO2010103374A3 Oily suspension containing probiotic bacteria for paradiatric uses
03/31/2011WO2010096170A3 Inhibition of trna synthetases and therapeutic applications thereof
03/31/2011WO2010080909A9 Compositions and methods of use of an oncolytic vesicular stomatitis virus
03/31/2011US20110077702 Means and Methods for Influencing Electrical Activity of Cells
03/31/2011US20110077679 Embolization device
03/31/2011US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals
03/31/2011US20110077158 Biocontrol of Storage Maladies of Potatoes by Bacterial Antagonists Produced in Co-Culture
03/31/2011US20110076338 Composition for Skin Protection and Methods of Making Same
03/31/2011US20110076330 Use of adipose tissue-derived stromal cells in spinal fusion
03/31/2011US20110076329 Graft prosthesis, material and methods
03/31/2011US20110076320 Stem cell cultivation devices and methods
03/31/2011US20110076316 Scalable matrix for the in vivo cultivation of bone and cartilage
03/31/2011US20110076294 Mixed Cell Populations For Tissue Repair And Separation Technique For Cell Processing
03/31/2011US20110076258 Methods of modulating t cell- dependent immune responses
03/31/2011US20110076257 Modified Nucleotide Sequence Encoding Glucagon-Like Peptide-1 (GLP-1), Nucleic Acid Construct Comprising Same for Production of Glucagon-Like Peptide-1 (GLP-1), Human Cells Comprising Said Construct and Insulin-Producing Constructs, and Method of Use Thereof
03/31/2011US20110076256 Human Neural Stem Cell and Pharmaceutical Composition for the Treatment of Central or Peripheral Nervous System Disorders or Injuries Using Same
03/31/2011US20110076255 Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
03/31/2011US20110076254 Porous scaffolds for stem cell renewal
03/31/2011US20110076253 Defined Culture Conditions of Human Embryonic Stem Cells
03/31/2011US20110076252 Compound and method for treatment of gastroesophageal reflux
03/31/2011US20110076250 Biodegradable Absorbents and Methods of Preparation
03/31/2011DE112009000125T5 Verwendung einer Zusammensetzung eines Kranbeeren-Derivats und D-Mannose, um Harnwegsinfektionen zu verhindern, zu kontrollieren und zu verbessern In order to prevent urinary tract infections to control use of a composition of a cranberry derivative and D-mannose, and to improve
03/31/2011CA2775642A1 Hyperblebbing shigella strains
03/31/2011CA2775050A1 Therapy for enteric infections
03/31/2011CA2774946A1 Identification of antigenic peptides from multiple myeloma cells
03/30/2011EP2302045A1 Enzymatic conversion of blood group B, and AB red blood cells using an alpha-galactosidase with unique substrate specificities and kinetic properties
03/30/2011EP2302039A1 Virus-like particles comprising HML-2 gag polypeptide
03/30/2011EP2302038A1 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses
03/30/2011EP2302032A1 Methods and compositions to modulate adhesion and stress tolerance in bacteria
03/30/2011EP2301583A1 Lentiviral vector-mediated gene transfer and uses thereof
03/30/2011EP2301573A1 Anti-cancer and anti-infectious disease compositions and methods for using same
03/30/2011EP2301567A1 Selective immune down regulation (SIDR) for transplantation
03/30/2011EP2301560A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
03/30/2011EP2301559A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
03/30/2011EP2301362A1 Mixture on the basis of a sourdough
03/30/2011EP2301343A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
03/30/2011EP2301333A1 Non-human sperm cell process system
03/30/2011EP2300604A1 Nitric oxide compositions and devices and methods for cosmesis
03/30/2011EP2300603A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections
03/30/2011EP2300602A1 Method to induce and expand therapeutic alloantigen- specific human regulatory t cells in large-scale
03/30/2011EP2300598A1 Use and methods for preventing and/or treating oral malodour
03/30/2011EP2300025A1 Treatment of gut motility disorders
03/30/2011EP2300024A1 Method for decreasing borborygmi by administering a bifidobacterium bacteria.
03/30/2011EP2300023A2 Microorganisms for preventing and treating neoplasms accompanying cellular therapy
03/30/2011EP2300022A2 Regulatory b cells and their uses
03/30/2011EP2299985A1 Diagnostic reagent, containing bioparticles, method for production thereof and use thereof as internal standard in nucleic acid preparation and nucleic acid detection methods
03/30/2011EP2299850A2 Liquid nutritional composition for bariatric surgery patients
03/30/2011EP1890713B1 Osteoblast composition of semi-solidified mixed fibrin for bone fracture agglutination and its manufacturing method
03/30/2011EP1337242B1 Gene delivery formulations for treatment of ischemic conditions
03/30/2011CN1863907B Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle
03/30/2011CN1814040B Compound liquid capsule of Chinese caterpillar fungus and quality control method
03/30/2011CN1787739B Sperm cell process system
03/30/2011CN1602351B Islet cells from human embryonic stem cells
03/30/2011CN101998998A Aminosugar compound and process for production thereof
03/30/2011CN101998965A Immunosuppressive polypeptides and nucleic acid
03/30/2011CN101998864A 调节t细胞依赖性免疫应答的方法 The method of regulating cell-dependent immune response t
03/30/2011CN101991880A Preparation consisting of PLGA (Polylactic Acid-Polyglycolic Acid)/TCP (Tris Calcium Polymer) and MSC (Mesenchymal Stem Cells) of compound MSC and application thereof
03/30/2011CN101991878A Preparation consisting of PLGA (Polylactic Acid-Polyglycolic Acid) and MSC (Mesenchymal Stem Cells) of compound MSC and application thereof
03/30/2011CN101991841A Medical composition for treating cancer and preparation method thereof
03/30/2011CN101991840A Method for preparing prostate cancer-resisting mussel enzymolytic extract and application thereof
03/30/2011CN101991839A Bone-strengthening musk analgesic paste and fingerprint measuring method of semi-finished products thereof
03/30/2011CN101991838A Medicinal composition for curing osteoproliferation, rheumatism, rheumatoid diseases and herniated disk
03/30/2011CN101991835A Formula and preparation method of Chinese material medical preparation with hair blackening function
03/30/2011CN101991834A External traditional Chinese medicine package for treating lumbar diseases
03/30/2011CN101991830A Medicament for treating infantile dyspepsia and preparation method thereof
03/30/2011CN101991829A Medicament for treating stomach illness
03/30/2011CN101991828A Medicine for treating wind-chill toothache and preparation method thereof
03/30/2011CN101991827A Preparation method of medicine for treating chilblain
03/30/2011CN101991818A Medicament for treating and resisting allergic diseases
03/30/2011CN101991817A Brain strengthening and nerve calming medicament
03/30/2011CN101991816A Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases
03/30/2011CN101991814A 一种具有祛风化痰和活血通络功能的制剂及制备方法 Formulation and preparation method of expelling phlegm and have Huoxuetongluo function
03/30/2011CN101991813A Preparation method of hair regrowth pills
03/30/2011CN101991807A Chinese herbal compound for treating liver cancer
03/30/2011CN101991804A Externally applied medicament for treating stomach illness
03/30/2011CN101991803A Traditional Chinese medicine preparation for treating habitual abortion
03/30/2011CN101991802A Chinese materia medica preparation for treating cold and cough
03/30/2011CN101991798A Medicament for treating apoplexy
03/30/2011CN101991794A Chinese traditional medicine preparation for treating eczema
03/30/2011CN101991793A Medicine for treating nonspecific ulcerative colitis
03/30/2011CN101991789A Preparation with functions of clearing away heat and toxic material and diminishing swelling and preparation method thereof
03/30/2011CN101991788A Preparation with effects of clearing heat and detoxicating, and diminishing swelling and relieving pain and preparation method thereof
03/30/2011CN101991784A Traditional Chinese medicine for curing childhood diarrhoea